Scorpius Holdings, Inc. (SCPX)
- Previous Close
0.1633 - Open
0.1616 - Bid 0.1610 x 800
- Ask 0.1713 x 1000
- Day's Range
0.1610 - 0.1750 - 52 Week Range
0.1400 - 0.8900 - Volume
305,857 - Avg. Volume
483,985 - Market Cap (intraday)
6.089M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 29, 2024 - May 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Scorpius Holdings Inc., through its subsidiary Scorpius BioManufacturing, operates as an integrated contract development and manufacturing organization. The company provides analytical testing, downstream process development, formulation optimization and development, and clinical biomanufacturing services to pharmaceutical and biotech companies. It is also involved in the provision of pre-clinical and product development; chemistry, manufacturing, and control analytical support; and bioassays. The company was formerly known as NightHawk Biosciences, Inc. and changed its name to Scorpius Holdings, Inc. in February 2024. Scorpius Holdings, Inc. was incorporated in 2008 and is based in Morrisville, North Carolina.
www.scorpiusbiologics.comRecent News: SCPX
Performance Overview: SCPX
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SCPX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SCPX
Valuation Measures
Market Cap
6.09M
Enterprise Value
13.13M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.17
Enterprise Value/Revenue
1.67
Enterprise Value/EBITDA
-0.28
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-33.80%
Return on Equity (ttm)
-82.92%
Revenue (ttm)
6.99M
Net Income Avi to Common (ttm)
-40.15M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
2.39M
Total Debt/Equity (mrq)
49.63%
Levered Free Cash Flow (ttm)
-26.34M